Clearside Biomedical Inc expected to post earnings of 16  cents a share - Earnings Preview

Clearside Biomedical,

08/03/2022 21:02

* Clearside Biomedical Inc  CLSD.OQ   CLSD.O  is expected
to show
a rise in quarterly revenue when it reports  results on March
10. 
    * The Alpharetta Georgia-based  company is expected to
report  a
161,460.6% increase in revenue to $17.772 million from $11
thousand a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Clearside
Biomedical Inc
is for earnings of 16 cents per share. For the same quarter last
year, the company reported a loss of 14 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Clearside
Biomedical Inc is $10​, above​ its last closing price of $1.36.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.10       -0.08      -0.08     Met     5.9
 Jun. 30 2021  -0.13       -0.13      -0.11     Beat    14.3
 Mar. 31 2021  -0.11       -0.10      -0.13     Missed  -32.7​
 Dec. 31 2020  -0.11       -0.11      -0.14     Missed  -22.8
 ​​Sep.        -0.11       -0.12      -0.05     Beat    57.1
 30 2020                                                
 Jun. 30 2020  -0.11       -0.12      -0.13     Missed  -9.6​
 Mar. 31 2020  -0.09       -0.11      -0.07     Beat    38.6
 Dec. 31 2019  0.03        -0.07      -0.07     Met     4.5
 This summary was machine generated March 8 at 21:02 GMT.  All
figures in US dollars  unless otherwise stated